This inventor holds 3 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research, Assistance Publique-Hopitaux De Paris. Active years: 2014-2019.
Company Filing History:
2 out of 5,383 
2 out of 1,853 
1 out of 331 
Years Active: 2014-2019
Title: Raphaël Scharfmann: Innovator in Diabetes Research
Introduction
Raphaël Scharfmann is a prominent inventor based in Paris, France. He has made significant contributions to the field of diabetes research, particularly in the development of human pancreatic beta cell lines. His work has the potential to advance diagnostic methods and treatment options for diabetes.
Latest Patents
Scharfmann holds 3 patents related to his innovative research. His latest patents include:
1. **Human pancreatic beta cell lines for diagnostic of diabetes** - This invention relates to a method for preparing commercial scale quantities of human functional beta cells and establishing cell lines. It also includes a diagnostic method using beta cell tumors or cells derived from them. The method involves a sub-transplantation procedure to enrich the graft in proliferating beta cells, allowing for the generation of human beta cell lines that express low amounts of insulin and have a gene expression profile similar to adult beta cells. These lines have demonstrated the ability to normalize glycemia in diabetic mice when transplanted, showcasing their insulin secretion capabilities.
2. **Production of a human beta cell line from an early postnatal pancreas** - This invention focuses on preparing commercial scale quantities of human functional beta cells from non-fetal pancreatic tissues. Similar to his previous patent, it involves a method for diagnosis using beta cell tumors or derived cells. The method also includes a sub-transplantation procedure to enrich the graft in proliferating beta cells, resulting in human beta cell lines that express, produce, and secrete insulin upon glucose stimulation. These lines have a gene expression profile resembling adult beta cells and can normalize glycemia in diabetic mice when transplanted.
Career Highlights
Scharfmann has worked with esteemed institutions such as the National Institute of Health and Medical Research and the Centre National de la Recherche Scientifique. His research has been pivotal in advancing our understanding of diabetes and the functionality of pancreatic beta cells.
Collaborations
Throughout his career, Scharfmann has collaborated with notable colleagues, including Paul Czernichow and Philippe Ravassard. These collaborations have further enriched his research and contributed to the scientific community's knowledge of diabetes.
Conclusion
Raphaël Scharfmann is a key figure in diabetes research, with a focus on developing innovative methods for creating human pancreatic beta cell lines. His patents and collaborations highlight